LindaWMartinMDMPH

Thoracic Surgery • Charlottesville, VA

Adult General Thoracic Surgery, Minimally Invasive Thoracic Surgery, Thoracic Surgical Oncology, Cardiovascular Surgery

Chief, Thoracic Surgery; Professor with Tenure, Thoracic Surgery; University of Virginia School of Medicine

Join to view full profile

Dr. Martin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Martin's full profile

Already have an account?

Office
1240 Lee St
Charlottesville, VA 22908
Phone+1 434-924-9333

Summary

Dr. Linda Martin is a thoracic surgeon in Charlottesville, VA and is affiliated with multiple hospitals in the area, including University of Virginia Medical Center, Emily Couric Clinical Cancer Center, and University of Virginia Medical Center. She received her medical degree from University of California San Diego School of Medicine and has been in practice 21 years. She specializes in adult general thoracic surgery, minimally invasive thoracic surgery, thoracic surgical oncology, and is experienced in fiberoptic bronchoscopy, laparoscopy, esophagectomy, adult general thoracic surgery, and thoracic surgical oncology.

Education & Training

University of Texas MD Anderson Cancer Center/University of Texas Medical School at HoustonFellowship, Thoracic Surgery, 2002 - 2004
University of California (San Francisco)Residency, Surgery, 2000 - 2002
University of MinnesotaResidency, Surgery, 1996 - 2000
University of California San Diego School of MedicineClass of 1996

Certifications & Licensure

CA State Medical License 1999 - Present
VA State Medical License 2016 - 2026
MD State Medical License 2007 - 2017
AL State Medical License 2014 - 2014
TX State Medical License 2004 - 2013
American Board of Surgery Surgery
American Board of Thoracic Surgery Thoracic and Cardiac Surgery

Awards, Honors, & Recognition

Patient Experience Award University of Virginia Health System, 2019-2024
Dean's Award for Clinical Excellence University of Virginia School of Medicine, 2022
Top Doctor Virginia Living Magazine, 2018
Carolyn Reed Best Paper Award Southern Thoracic Surgical Association, 2017
Top Doctor Baltimore Magazine, 2015
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) Start of enrollment: 2015 Feb 11
Active, not recruiting
Phase 3
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) Start of enrollment: 2014 Sep 26
Recruiting
Not Applicable
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) Start of enrollment: 2015 Mar 23
Recruiting
Phase 3
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer Start of enrollment: 2015 Jul 01
Recruiting
Phase 3
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) Start of enrollment: 2016 Jul 22
Active, not recruiting
Phase 3
Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes Start of enrollment: 2017 Sep 29
Terminated
Phase 3
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) Start of enrollment: 2018 Apr 24
Active, not recruiting
Phase 3
Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery Start of enrollment: 2019 May 03
Suspended
Phase 2, Phase 3
CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer Start of enrollment: 2021 Mar 10
Active, not recruiting
Phase 2
Study of ECHELON ENDOPATH(TM) Staple Line Reinforcement Start of enrollment: 2020 Sep 29
Completed
Not Applicable
Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE) Start of enrollment: 2024 Feb 22
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

18 citations
Is less really more? Reexamining video-assisted thoracoscopic versus open lobectomy in the setting of an enhanced recovery protocol
Elizabeth D. Krebs, J. Hunter Mehaffey, Bethany M. Sarosiek, Randal S. Blank, Christine L. Lau
The Journal of Thoracic and Cardiovascular Surgery. 2019-09-13
89 citations
COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network.
Mara B. Antonoff, Leah M. Backhus, Daniel J. Boffa, Stephen Broderick, Lisa M. Brown
The Journal of Thoracic and Cardiovascular Surgery. 2020-08-01
4 citations
Use of endoscopic ultrasound in pre-treatment staging of esophageal cancer did not alter management plan.
Mark J. Radlinski, Linda W. Martin, Dustin M. Walters, Patrick G. Northup, Andrew Y. Wang
Journal of Thoracic Disease. 2020-09-15

Authored Content

Surgery in Stage IIIA Lung Cancer8/1/2017
Robotic Thoracic Surgery: Robotic Operations in Thoracic Surgery: Who is a candidate?6/1/2017
Enhanced Recovery Pathways in Thoracic Surgery1/23/2017

Press Mentions

16. Evaluating the Lung Cancer Screening Eligibility of Patients Undergoing Lung Cancer Operations: An Analysis of the Southern Community Cohort StudyMay 6th, 2023
FDA Approves Drug Which Makes Lung Cancer GlowDecember 29th, 2022
FDA Approves Cancer-Targeting Imaging Agent for Lung CancerDecember 19th, 2022
Join now to see all

Grant Support

Carolyn E. Reed Travelling FellowshipThoracic Surgery Foundation for Research and Education and Women in Thoracic Surgery2014

Committees

Vice Chair 2024-2026; Chair-Elect 2024-2026; Executive Board Member 2017-present, General Thoracic Surgical Club 2024 - Present
Chair, Alliance Thoracic Surgery Committee 2022 - Present
Vice Chair, Respiratory Committee, Alliance 2022 - Present
Member, STS Workforce on CT Surgery Practice Models 2020 - Present
Task Force Leader - Triage for Appropriate Treatment, National Lung Cancer Roundtable - America Cancer Society 2017 - Present
Member, STS E-learning and Educational Innovation Curriculum Task Force 2017 - Present
Content Developer/Editor, ACS SESAP (Surgical Education and Self Assessment Program) 2017 - Present
Steering Committee Member, Respiratory Committee - Alliance 2016 - Present
Member, Alliance Dissemination and Implementation Committee 2016 - Present
Member, Alliance Cancer Care Standards Development 2013 - Present
member, STS Tech-Con Workforce 2018 - 2021
member, STS General Thoracic Surgery Workforce 2017 - 2022
Member, STS Workforce on Media Relations and Communications 2016 - 2022
Content Developer/Editor, American Board of Surgery In Training Exam 2015 - 2016